Deutsche Märkte geschlossen

Pfizer Inc. (PFE)

NYSE - Nasdaq Echtzeitpreis. Währung in USD
Zur Watchlist hinzufügen
28,91-1,56 (-5,12%)
Börsenschluss: 04:00PM EST
28,91 0,00 (0,00%)
Nachbörse: 07:59PM EST

Pfizer Inc.

66 Hudson Boulevard East
New York, NY 10001-2192
United States
212 733 2323
https://www.pfizer.com

Sektor(en)Healthcare
BrancheDrug Manufacturers - General
Vollzeitmitarbeiter83.000

Leitende Angestellte

NameTitelZahlenAusgeübtGeburtsjahr
Dr. Albert Bourla D.V.M., Ph.D.Chairman of the Board & CEO11,72MN/A1962
Mr. David M. DentonChief Financial Officer & Executive VP18,19MN/A1965
Dr. Mikael Dolsten M.D., Ph.D.Chief Scientific Officer and President of Research & Development5,82MN/A1958
Ms. Angela HwangChief Commercial Officer & President of Global Biopharmaceuticals Business4,89M7,7M1966
Ms. Jennifer B. DamicoSenior VP, Controller & Principal Accounting OfficerN/AN/A1968
Ms. Lidia L. FonsecaExecutive VP and Chief Digital & Technology OfficerN/AN/A1969
Ms. Francesca M. DeMartinoChief Investor Relations OfficerN/AN/AN/A
Mr. Douglas M. LanklerExecutive VP & General Counsel3,78M1,85M1966
Mr. Rady A. JohnsonExecutive VP and Chief Compliance, Quality & Risk OfficerN/AN/A1962
Mr. Andreas J. PanayiotouGlobal Chief Marketing OfficerN/AN/AN/A
Die Beträge haben den Stand 31. Dezember 2022 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in USD.

Beschreibung

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Retacrit, Lorbrena, and Braftovi brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc., as well as strategic partnership with CSPC Pharmaceutical Group Limited to launch a local brand of the COVID-19 oral therapeutic treatment Nirmatrelvir/Ritonavir in China, and a collaboration with Carrick Therapeutics Limited. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Corporate Governance

Pfizer Inc.s ISS Governance QualityScore, Stand 1. Dezember 2023, lautet 5. Die grundlegenden Scores sind Audit: 10, Vorstand: 5, Shareholderrechte: 1, Kompensation: 3.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.